Navigation Links
New Argonne study may shed light on protein-drug interactions

ARGONNE, Ill. (January 15, 2008) -- Proteins, the biological molecules involved in virtually every action of every organism, may themselves move in surprising ways, according to a recent study from the U.S. Department of Energys Argonne National Laboratory that may shed new light on how proteins interact with drugs and other small molecules.

While scientists had expected proteins to behave similarly in regions of high and low protein concentration from as high as 30 percent protein to less than one percent protein, respectively they instead found that proteins had a much larger range of motion and could contort themselves into many more configurations in the dilute solutions. The difference is comparable to skipping through an open field or being crammed into a crowded elevator, said Argonne biochemist Lee Makowski, who headed the project.

This study represents a novel approach to characterizing the ways in which proteins move around in solution to interact with other molecules, including drugs, metabolites, or pieces of DNA, and relied on the intense x-ray beams available at Argonnes Advanced Photon source.

The study of proteins had long focused almost exclusively on their structures, parts of which can resemble chains, sheets or helices. To determine these, scientists use high-energy X-rays to take snapshots of proteins frozen in a single conformation within a highly ordered crystal. However, biologists had made relatively little progress in using these pictures to show how proteins can reconfigure themselves in different environments.

Proteins are not static, theyre dynamic, Makowski said. Part of the common conception of proteins as rigid bodies comes from the fact that we know huge amounts about protein structures but much less about how they move.

For over a century, the standard model of protein behavior depicted them as inflexible locks that could interact only with a small set of equally rigid molecular keys. Even todays introductory biology courses rely on descriptions of protein behavior that require them to swivel and pivot very little as they interact with other biological molecules, according to Makowski. Thats a very powerful image but its not the whole story, he said. Weve learned that proteins in solution can take on an entire ensemble of slightly different structures, and that, for most proteins, this ensemble grows much larger as you go to smaller and smaller concentrations.

Makowski and his colleagues were also surprised to discover that environmental conditions strongly influence which state in this ensemble of conformations a protein prefers to enter. Most of a proteins common configurations have a functional purpose, he said, as it is not likely to twist itself into something completely irrelevant to its function.

For example, one of the five proteins examined in the study, hemoglobin, has two favored conformations: one in which it binds oxygen very readily and one in which it does not. When hemoglobin is placed in a solution that contains a great deal of available oxygen, it spends most of the time in the former state, while if oxygen is not available, it usually flips into the latter. We now know that in dilute solutions, hemoglobin actually can take on both conformations - even in the absence of oxygen, he said.

By keeping all of the environmental factors the same save for the protein concentration in the solution, Makowski and his team discovered another surprising result. Scientists had known for many years that when proteins are too concentrated, they aggregate and fall out of solution. However, biochemists previously had difficulty explaining why a similar effect also occurs in overly dilute solutions.

Proteins have hydrophobic or water-hating core regions that try to avoid touching water if at all possible. Because of this characteristic, proteins will rearrange themselves to protect these regions from coming into contact with water. In dilute solutions, however, Makowskis team discovered that proteins fluctuate far more than in concentrated solutions, and these fluctuations expose the hydrophobic core of the proteins, making them more likely to stick to one another or to the walls of the container.


Contact: Steve McGregor
DOE/Argonne National Laboratory

Related biology news :

1. Argonne National Lab acquires first SiCortex SC5832
2. Argonne helps China create cleaner Beijing for 2008 Olympics
3. Sea otter study reveals striking variability in diets and feeding strategies
4. Study: weight-loss tips differ in African-American, mainstream magazines
5. Study helps explain how allergic reactions are triggered
6. Selective restraints and reduced medication could reduce nursing home falls says 4-year study
7. Study locates cholesterol genes; finds surprises about good, bad cholesterol
8. Study suggests genetic connection between short stature and arthritis
9. Radioactive understudy may aid medical imaging, drug development
10. Surprise -- cholesterol may actually pose benefits, study shows
11. Hybridization partially restores vision in cavefish, NYU study finds
Post Your Comments:
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
(Date:10/23/2015)... , Oct. 23, 2015 Research and ... the "Global Voice Recognition Biometrics Market 2015-2019" ... --> The global voice recognition biometrics ... 2014-2019. --> --> ... has been prepared based on an in-depth market analysis ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT . ... a corporate overview. th Annual Oppenheimer Healthcare Conference ... a.m. PT . Jim Mazzola , vice president of ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology: